Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer
Year: 2011
Type: article
Study design: Clinical Trial
Source: Urology
Institutions: University of Washington, Institut Gustave Roussy, Cedars-Sinai Medical Center, Johns Hopkins University, Johns Hopkins Medicine, Fox Chase Cancer Center, University of Chicago, Azienda Ospedaliera San Camillo-Forlanini, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Bristol-Myers Squibb (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1987008543
